Advanced Pharmacology Practice Exam – 2026 Edition with Rationales Section 1: Pharmacokinetics and Pharmacodynamics (Questions 1-15)

Advanced Pharmacology Practice Exam – 2026
Edition with Rationales
Section 1: Pharmacokinetics and
Pharmacodynamics (Questions 1-15)
1. A patient with renal impairment is prescribed a medication that is primarily eliminated renally.
Which pharmacokinetic process is most affected?

 A) Absorption

 B) Distribution

 C) Metabolism

 D) Excretion

Answer: D) Excretion
Rationale: Renal impairment directly affects drug excretion, as the kidneys are the primary organs
responsible for eliminating many drugs and their metabolites. Decreased glomerular filtration rate (GFR)
leads to drug accumulation and potential toxicity.

2. A medication has a half-life of 4 hours. How many half-lives will it take for the drug to reach steady-
state concentration?

 A) 2 half-lives

 B) 3 half-lives

 C) 4 half-lives

 D) 5 half-lives

Answer: D) 5 half-lives
Rationale: It takes approximately 5 half-lives to reach steady-state concentration (about 97% of steady-
state). Steady-state occurs when drug administration equals drug elimination.

3. Which route of administration provides the fastest onset of action?

 A) Oral

 B) Subcutaneous

 C) Intravenous

 D) Intramuscular

,Answer: C) Intravenous
Rationale: Intravenous administration delivers the drug directly into the bloodstream, bypassing
absorption barriers and providing immediate therapeutic effect.

4. The nurse understands that drug bioavailability is highest with which route?

 A) Oral

 B) Sublingual

 C) Intravenous

 D) Topical

Answer: C) Intravenous
Rationale: IV administration has 100% bioavailability because the drug enters the systemic circulation
directly without first-pass metabolism or absorption barriers.

5. A patient is taking warfarin and is prescribed amiodarone. The nurse anticipates which drug
interaction?

 A) Decreased warfarin effect

 B) Increased warfarin effect

 C) No change in warfarin effect

 D) Complete reversal of warfarin effect

Answer: B) Increased warfarin effect
Rationale: Amiodarone inhibits CYP2C9 and CYP1A2, which metabolize warfarin, leading to increased
warfarin levels and increased risk of bleeding.

6. The therapeutic index of a drug is defined as:

 A) The ratio of effective dose to lethal dose

 B) The amount of drug bound to plasma proteins

 C) The volume of distribution

 D) The rate of drug absorption

Answer: A) The ratio of effective dose to lethal dose
Rationale: The therapeutic index (TI) is the ratio of the toxic dose to the therapeutic dose (TD50/ED50). A
narrow TI indicates a drug with a small margin of safety.

7. Which phase of drug metabolism involves conjugation reactions?

 A) Phase I

 B) Phase II

 C) Phase III

,  D) Phase IV

Answer: B) Phase II
Rationale: Phase II metabolism involves conjugation reactions where polar groups are attached to the
drug molecule, making it more water-soluble for excretion.

8. A patient with hepatic cirrhosis has decreased albumin levels. How will this affect drug distribution?

 A) Decreased free drug concentration

 B) Increased free drug concentration

 C) No change in free drug concentration

 D) Decreased drug half-life

Answer: B) Increased free drug concentration
Rationale: Low albumin levels result in less protein binding, leading to increased free (unbound) drug
concentrations and potential toxicity.

9. The nurse understands that the blood-brain barrier restricts drug passage due to:

 A) High lipid solubility requirement

 B) High water solubility requirement

 C) Presence of large pores

 D) Absence of tight junctions

Answer: A) High lipid solubility requirement
Rationale: The blood-brain barrier has tight junctions and requires drugs to be lipid-soluble to cross via
passive diffusion. Water-soluble drugs have difficulty crossing.

10. Which medication class would require monitoring of serum drug levels due to a narrow
therapeutic index?

 A) Penicillins

 B) Cephalosporins

 C) Aminoglycosides

 D) Macrolides

Answer: C) Aminoglycosides
Rationale: Aminoglycosides have a narrow therapeutic index and require therapeutic drug monitoring to
prevent nephrotoxicity and ototoxicity.

11. First-pass metabolism primarily occurs in which organ?

 A) Kidneys

 B) Liver

,  C) Lungs

 D) Heart

Answer: B) Liver
Rationale: First-pass metabolism occurs in the liver, where drugs absorbed from the GI tract are
metabolized before reaching systemic circulation.

12. A drug with high protein binding is administered to a patient with malnutrition. What effect
should the nurse anticipate?

 A) Decreased therapeutic effect

 B) Increased therapeutic effect

 C) No change in therapeutic effect

 D) Decreased drug half-life

Answer: B) Increased therapeutic effect
Rationale: Malnutrition leads to decreased protein levels, resulting in less protein binding and higher free
drug concentrations, enhancing therapeutic effects and toxicity risk.

13. Which CYP450 enzyme is responsible for metabolizing warfarin?

 A) CYP1A2

 B) CYP2C9

 C) CYP3A4

 D) CYP2D6

Answer: B) CYP2C9
Rationale: CYP2C9 is the primary enzyme responsible for metabolizing S-warfarin, the more active isomer
of warfarin.

14. The process by which drugs are transported across cell membranes against a concentration
gradient requires:

 A) Passive diffusion

 B) Facilitated diffusion

 C) Active transport

 D) Filtration

Answer: C) Active transport
Rationale: Active transport requires energy (ATP) to move drugs against a concentration gradient and
involves carrier proteins.

15. The nurse understands that drug tolerance occurs when: